Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nilofer S Azad

Showing results (1-10 of 109) with videos related to

Pageof 11
Sort By:
Preventive Medicine|July 1, 2020
Response to McNamara's comment on "Cost-utility of colorectal cancer screening at age 40 years old for average-risk patients" by Azad et alIra L Leeds, Nilofer S Azad
Cancers|April 14, 2025
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant SettingKai-Li Liang, Nilofer S Azad
Nature Reviews. Gastroenterology & Hepatology|June 14, 2024
Unlocking the promise of RAS inhibition in pancreatic cancerSaurav D Haldar, Nilofer S Azad
Chinese Clinical Oncology|February 4, 2020
Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)Christopher D Jakubowski, Nilofer S Azad
Oncology (Williston Park, N.Y.)|April 8, 2014
The utility of molecular testing in colorectal cancer: the promise needs progressNilofer S Azad, Luis A Diaz
Therapeutic Advances in Medical Oncology|March 7, 2024
Immunotherapy for the treatment of biliary tract cancer: an evolving landscapeHelen Catherine Wilbur, Nilofer S Azad
The Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S Azad
Drug Discovery Today|September 11, 2007
The ongoing evolution of proteomics in malignancyAmit S Dhamoon, Elise C Kohn, Nilofer S Azad
Hepatology (Baltimore, Md.)|January 24, 2024
Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitationsH Catherine Wilbur, Heloisa P Soares, Nilofer S Azad
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The DNA Damaging Revolution: PARP Inhibitors and BeyondTimothy A Yap, Ruth Plummer, Nilofer S Azad, et al.
Pageof 11

Showing results (1-10 of 109) with videos related to

Sort By:
Pageof 11
Preventive Medicine|July 1, 2020
Response to McNamara's comment on "Cost-utility of colorectal cancer screening at age 40 years old for average-risk patients" by Azad et alIra L Leeds, Nilofer S Azad
Cancers|April 14, 2025
Immune-Based Strategies for Pancreatic Cancer in the Adjuvant SettingKai-Li Liang, Nilofer S Azad
Nature Reviews. Gastroenterology & Hepatology|June 14, 2024
Unlocking the promise of RAS inhibition in pancreatic cancerSaurav D Haldar, Nilofer S Azad
Chinese Clinical Oncology|February 4, 2020
Immune checkpoint inhibitor therapy in biliary tract cancer (cholangiocarcinoma)Christopher D Jakubowski, Nilofer S Azad
Oncology (Williston Park, N.Y.)|April 8, 2014
The utility of molecular testing in colorectal cancer: the promise needs progressNilofer S Azad, Luis A Diaz
Therapeutic Advances in Medical Oncology|March 7, 2024
Immunotherapy for the treatment of biliary tract cancer: an evolving landscapeHelen Catherine Wilbur, Nilofer S Azad
The Lancet. Oncology|March 6, 2020
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright futureEric S Christenson, Elizabeth Jaffee, Nilofer S Azad
Drug Discovery Today|September 11, 2007
The ongoing evolution of proteomics in malignancyAmit S Dhamoon, Elise C Kohn, Nilofer S Azad
Hepatology (Baltimore, Md.)|January 24, 2024
Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitationsH Catherine Wilbur, Heloisa P Soares, Nilofer S Azad
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
The DNA Damaging Revolution: PARP Inhibitors and BeyondTimothy A Yap, Ruth Plummer, Nilofer S Azad, et al.
Pageof 11